全文获取类型
收费全文 | 63361篇 |
免费 | 6200篇 |
国内免费 | 4850篇 |
专业分类
耳鼻咽喉 | 638篇 |
儿科学 | 688篇 |
妇产科学 | 618篇 |
基础医学 | 7677篇 |
口腔科学 | 1111篇 |
临床医学 | 8283篇 |
内科学 | 9112篇 |
皮肤病学 | 593篇 |
神经病学 | 3499篇 |
特种医学 | 2507篇 |
外国民族医学 | 34篇 |
外科学 | 6704篇 |
综合类 | 11048篇 |
现状与发展 | 16篇 |
一般理论 | 1篇 |
预防医学 | 4279篇 |
眼科学 | 1849篇 |
药学 | 6805篇 |
49篇 | |
中国医学 | 3324篇 |
肿瘤学 | 5576篇 |
出版年
2024年 | 71篇 |
2023年 | 946篇 |
2022年 | 1512篇 |
2021年 | 2949篇 |
2020年 | 2485篇 |
2019年 | 2171篇 |
2018年 | 2302篇 |
2017年 | 2036篇 |
2016年 | 1942篇 |
2015年 | 3091篇 |
2014年 | 3720篇 |
2013年 | 3160篇 |
2012年 | 4955篇 |
2011年 | 5472篇 |
2010年 | 3517篇 |
2009年 | 2584篇 |
2008年 | 3292篇 |
2007年 | 3509篇 |
2006年 | 3353篇 |
2005年 | 3470篇 |
2004年 | 2208篇 |
2003年 | 2101篇 |
2002年 | 1752篇 |
2001年 | 1402篇 |
2000年 | 1576篇 |
1999年 | 1620篇 |
1998年 | 1062篇 |
1997年 | 1002篇 |
1996年 | 758篇 |
1995年 | 712篇 |
1994年 | 677篇 |
1993年 | 398篇 |
1992年 | 482篇 |
1991年 | 433篇 |
1990年 | 372篇 |
1989年 | 317篇 |
1988年 | 239篇 |
1987年 | 221篇 |
1986年 | 168篇 |
1985年 | 114篇 |
1984年 | 66篇 |
1983年 | 59篇 |
1982年 | 43篇 |
1981年 | 31篇 |
1980年 | 14篇 |
1979年 | 23篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1975年 | 4篇 |
1973年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
61.
Jinjin Jiang Xinru Zhang Yue Tang Shuhan Li Jing Chen 《Fundamental & clinical pharmacology》2021,35(1):4-24
Age‐related macular degeneration (AMD) and glaucoma are global ocular diseases with high blindness rate. RNA interference (RNAi) is being increasingly used in the treatment of these disorders with siRNA drugs, bevasiranib, AGN211745 and PF‐04523655 for AMD, and SYL040012 and QPI‐1007 for glaucoma. Administration routes and vectors of gene drugs affect their therapeutic effect. Compared with the non‐viral vectors, viral vectors have limited payload capacity and potential immunogenicity. This review summarizes the progress of the ocular siRNA gene‐silencing therapy by focusing on siRNA drugs for AMD and glaucoma already used in clinical research, the main routes of drug delivery and the non‐viral vectors for siRNA drugs. 相似文献
62.
Background:The purpose of this experiment is to evaluate the impact of the care of Parkinson disease nurse specialist on improving motor symptoms and life quality for patients with Parkinson disease (PD).Method:This is a randomized controlled research, and it will be conducted from April 2021 to October 2021 at Sichuan Provincial People''s Hospital. The experiment was granted through the Research Ethics Committee of Sichuan Provincial People''s Hospital (004510293). All the patients suffer from PD, age 18 years or older, both female and male, regardless of the duration or severity of this disease are eligible. The exclusion criteria contains: lack sufficient knowledge to complete questionnaires, serious physical comorbidities or refuse to take part in the program. In our experiment, the major result measures are motor symptoms and life quality. For the measurement of life quality, we will utilize Parkinson disease Questionnaire-39, the most extensively utilized the scale of life quality in PD. The evaluation of motor symptoms severity is carried out with the revision of Unified Parkinson Disease Rating Scale sponsored by Movement Disorder Society.Results:Table 1 indicates clinical outcomes at different time points.Conclusion:The Parkinson''s disease nurse specialist care may promote the life quality in the PD patients.Trial registration number:researchregistry 6284. 相似文献
63.
Yuxin Huang Yuanyuan Xu Jieyuzhen Qiu Cuiping Jiang Wen Tan Xiaoming Tao Qin Gu Jiao Sun 《Medicine》2021,100(13)
This study was aimed at assessing the impact of the dusk phenomenon on the total glucose exposure in Chinese people with type 2 diabetes.A total of 380 type 2 diabetes who received a retrospective continuous glucose monitoring system (CGMs) for 72 hours were enrolled in our study, 32 of them failed in CGMs. The patients were first divided into 2 groups: dusk phenomenon (n = 95) and non dusk phenomenon group (n = 253). The magnitude of the dusk phenomenon (δDusk) was quantified by pre-dinner glucose minus post-lunch 2 hours glucose. A persistent δDusk ≥ 0 or a once only δDusk < 0 can be diagnosed with the dusk phenomenon. The participants were secondarily matched for the post-lunch 2 hours glucose to assess the impact of the dusk phenomenon on the overall glucose exposure. The impact of the dusk phenomenon was assessed on high-performance liquid chromatography assay (HbA1c) and 24-hour mean glucose.There were 95 of 348 (27.3%) participants with the dusk phenomenon in the overall population, and the median of δDusk level was –0.8 (–1.8, 0.2) mmol/L. The median of glucose differences between the 2 paired groups were 0.4 (–0.4, 1.0)% for HbA1c, 0.9 (0.2, 1.4) mmol/L for 24 hours mean glucose. The correlation analysis showed no relationship between the magnitude of dawn phenomenon and the dusk phenomenon (r = 0.052, P = .472).The incidence of dusk phenomenon is about 27.3% in people with type 2 diabetes. The impacts of dusk phenomenon on HbA1c and 24-hour mean glucose were about 0.4% and 0.9 mmol/L and the dusk phenomenon was not related with the dawn phenomenon. 相似文献
64.
65.
66.
Jie Li Megan M. Kaneda Jun Ma Ming Li Ryan M. Shepard Kunal Patel Tomoyuki Koga Aaron Sarver Frank Furnari Beibei Xu Sanjay Dhawan Jianfang Ning Hua Zhu Anhua Wu Gan You Tao Jiang Andrew S. Venteicher Jeremy N. Rich Christopher K. Glass Judith A. Varner Clark C. Chen 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(16)
67.
目的 借助网络药理学的方法,探究两组王琦教授新冠肺炎预防方(简称预防方)预防新型冠状病毒肺炎(COVID-19)的分子靶点和机制。方法 通过TCMSP数据库检索并筛选其活性成分及其作用靶点,通过Uniprot数据库进行蛋白标准化处理。从Genecards数据库中以“Novel coronavirus pneumonia”为关键词搜索获取COVID-19的靶标,构建相交靶点韦恩图。通过cytoscape3.7.2构建PPI蛋白互作网络,寻找富集数目最多的靶点。通过R语言对预防方治疗COVID-19的靶点进行GO和KEGG富集分析,并绘制气泡图。结果 预防方与新冠肺炎相关靶点涉IL-6、TNF、CXCL8、VEGFA、MMP9;GO功能富集分析分别获得53、57条通路;27、29条KEGG相关信号通路。结论 王琦教授新冠肺炎预防方中的主要活性成分为槲皮素、山奈酚、木犀草素、β-谷甾醇、植物甾醇等,可能通过作用于IL-6、TNF、CXCL8、VEGFA、MMP9、CXCL8、IL10、CCL2、IL1B等靶点和介导TNF信号通路、T细胞受体信号通路、Toll样受体信号通路等发挥作用,从而促进免疫反应、炎症反应及细菌防御反应,预防COVID-19。 相似文献
68.
69.
70.
Xiang Yu Ben Wang ShaoMin Yang SongBo Han Liang Jiang XiaoGuang Liu Feng Wei FengLiang Wu Lei Dang ZhongJun Liu 《The spine journal》2019,19(3):509-515